Clinic of Lipid Disease of Quebec

The Clinic of Lipid Disease of Quebec (Clinique des maladies lipidiques de Québec) is a specialized clinical research and medical center located in Quebec City, Canada. Affiliated with the CHU de Québec-Université Laval, it is recognized as a leading site for the study and treatment of complex lipid disorders and cardiovascular risk factors. The clinic is heavily involved in international clinical trials, contributing to the development of novel therapeutic modalities such as PCSK9 inhibitors, antisense oligonucleotides, and siRNA therapies. Its research focus encompasses familial hypercholesterolemia, severe hypertriglyceridemia, and the prevention of atherosclerosis. By bridging academic research with clinical practice, the center provides patients with access to emerging treatments while advancing the global understanding of metabolic health. It serves as a critical partner for major pharmaceutical companies in the cardiovascular and metabolic space.